Search Email Updates Contact Us Residents Business Visitors Government Office of the Mayor NYC.gov always open
Search:
Michael A. Stocker, M.D., Chairman of the Board - Alan D. Aviles, President HHC - New York Health and Hospitals Corporation
HHC InFocus - Understanding Our Quality & Safety Performance
Preventing Infections

Ventilator-Associated Pneumonia

Ventilator-Associated Pneumonia (VAP) is a particular risk for patients who are on mechanical ventilation for more than 48 hours. It is an infection of the lung which makes oxygen exchange difficult for patients.

Beginning in 2005, a majority of the adult intensive care units in HHC hospitals participated in a Critical Care Collaborative program to dramatically reduce hospital-acquired infections by consistently following a "bundle " of evidence-based clinical practices. Shown below are the rates reported by the ICUs in the Collaborative.
 

Ventilator-Associated Pneumonia Infection Rates -
ICUs In Critical Care Collaborative
Rates per 1000 Ventilator Days



Hospital-Specific Data
Ventilator-Associated Pneumonia

Beginning in 2008, HHC collected ventilator-associated pneumonia infection data from all of the adult ICUs in its 11 hospitals, not just those that participated in the Collaborative. Below is the corporate rate that includes all ICUs.

Ventilator-Associated Pneumonia Infection Rates - All ICUs
Rates per 1000 Ventilator Days


Hospital-Specific Data
Ventilator-Associated Pneumonia

Over the last five years, the rates of VAP in our ICUs dropped to 1.5 in 2010 from 10.5 in 2005, when we began to report statistics for those ICUs in the Critical Care Collaborative. Of 27 adult ICUs, 19 went five months or more without a VAP, with 15 of the 27 having no VAP cases for the whole of 2010.




Copyright 2012 The City of New York Contact Us | FAQs | Privacy Policy | Terms of Use | Site Map